Regulation of ENaC byphosphoinositides may underlie insulin (INS, P01308)‐evoked renalNa+ retention that can complicate the clinical management of type 2diabetes using insulin‐sensitizing thiazolidinedione drugs [121]. This evidence concerns the gene INS and type 2 diabetes mellitus.